QQ客服 官方微博 反馈留言

	Inhibition of AKT sensitizes chemoresistant ovarian cancer cells to cisplatin by abrogating S and G2/M arrest (vol 100, pg 506, 2016)
	Zhang, Di; Piao, Hai-Lan; Li, Yan-Hong; Qiu, Qing; Li, Da-Jin; Du, Mei-Rong; Tsang, Benjamin K.
刊名	EXPERIMENTAL AND MOLECULAR PATHOLOGY
	2016
卷号	101期号:1
ISSN号	0014-4800
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3622339
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Zhang, Di,Piao, Hai-Lan,Li, Yan-Hong,et al. Inhibition of AKT sensitizes chemoresistant ovarian cancer cells to cisplatin by abrogating S and G2/M arrest (vol 100, pg 506, 2016)[J]. EXPERIMENTAL AND MOLECULAR PATHOLOGY,2016,101(1).
APA	Zhang, Di.,Piao, Hai-Lan.,Li, Yan-Hong.,Qiu, Qing.,Li, Da-Jin.,...&Tsang, Benjamin K..(2016).Inhibition of AKT sensitizes chemoresistant ovarian cancer cells to cisplatin by abrogating S and G2/M arrest (vol 100, pg 506, 2016).EXPERIMENTAL AND MOLECULAR PATHOLOGY,101(1).
MLA	Zhang, Di,et al."Inhibition of AKT sensitizes chemoresistant ovarian cancer cells to cisplatin by abrogating S and G2/M arrest (vol 100, pg 506, 2016)".EXPERIMENTAL AND MOLECULAR PATHOLOGY 101.1(2016).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。